Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and Cough
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Charles L Daley, MD
National Jewish Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama - Birmingham
Birmingham, Alabama, United States
- National Jewish Hospital
Denver, Colorado, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- Louisiana State University
New Orleans, Louisiana, United States
- Johns Hopkins
Baltimore, Maryland, United States
- Southeastern Research Center
Winston-Salem, North Carolina, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Jefferson Hospital
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Texas - Tyler
Tyler, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Oct 2022
- Primary completion
- 1 Feb 2024
- Completion
- 1 Feb 2024
- Last update posted
- 23 Jul 2025
- Registered enrollment
- 40
- Registry id
- NCT05495243
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.